Roland Six
Vrije Universiteit Brussel
21 Papers
237 Citations
Roland Six is an academic researcher from Vrije Universiteit Brussel. The author has contributed to research in topics: Ambulatory blood pressure & Blood pressure. The author has an hindex of 9, co-authored 21 publications.
Chat about Author
Papers
Prognostic value of ambulatory blood-pressure recordings in patients with treated hypertension
Denis Clement,Marc De Buyzere,Dirk De Bacquer,Peter W. de Leeuw,Daniel A. Duprez,Robert Fagard,P Gheeraert,Luc Missault,Jacob J. Braun,Roland Six,Patricia Van der Niepen,Eoin O'Brien +11 more
TL;DR: In patients with treated hypertension, a higher ambulatory systolic or diastolic blood pressure predicts cardiovascular events even after adjustment for classic risk factors including office measurements of blood pressure.
Effect of carvedilol on ambulatory blood pressure, renal hemodynamics, and cardiac function in essential hypertension.
Alain Dupont,P. Van der Niepen,Y. Taeymans,Michel Ingels,Amnon Piepsz,Axel Bossuyt,Pierre Block,Roland Six,Marc Jonckheer,Luc Vanhaelst +9 more
TL;DR: It is concluded that carvedilol possesses definite antihypertensive and renal vasodilating properties, both acutely and after chronic treatment.
59
Patient compliance and therapeutic coverage - comparison of amlodipine and slow-release nifedipine in the treatment of hypertension.
TL;DR: In this article, patient compliance in hypertensive outpatients amlodipine (5 mg once daily) and slow-release nifedipine(20 mg twice daily) were compared in an open, crossover study in general practices.
53
•Journal Article
Patient Compliance and Therapeutic Coverage - Comparison of Amlodipine and Slow-release Nifedipine in the Treatment of Hypertension (vol 47, Pg 477, 1995)
TL;DR: Patient compliance and therapeutic coverage with the calcium antagonist amlodipine given once daily was superior to slow release nifedipine b.
36
•Journal Article
Antihypertensive efficacy of low dose torasemide in essential hypertension: a placebo-controlled study.
TL;DR: This low dose of torasemide 2.5 mg once daily appears to be the recommended dose for starting antihypertensive treatment with this compound and is well tolerated in patients with mild to moderate hypertension.
23